Experts Think Merck's Gardasil Could Be Widely Distributed (MRK)

According to a tweet from BlueShift Capital, Merck's MRK Gardasil vaccine could be more widely distributed and used after a recent study by H Lee Moffitt Cancer Center. This is according to experts in the industry. Shares of Merck are up 22 cents to $33.38, a gain of 0.66%.